Zomedica Corp. Common Shares (ZOM) earnings
ZOM earnings moved a median of +2.47% by the close. Quarterly and annual ZOM reports and results, each read against the price at its own news timestamp. Back to the ZOM overview →
10 measured ZOM earnings events.
Where these ZOM earnings landedvs 10 measured ZOM earnings reactions
| Middle 50% of ZOM earnings reactions | -0.73% to +4.95% |
|---|---|
| Median reaction (to close) | +2.47% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 ZOM earnings events with a measured close landed between -0.73% and +4.95%; 60% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Zomedica Corp. For: Jun 30 | SEC filing · Form 10-Q | -2.37% | +3.79% | |
| Zomedica Announces "Fifth Friday at Four" Webinar on May 29th: First Quarter 2026 Financial Results and a Deep Dive into the Companion Animal VetTech Market | Press release | -1.85% | -0.71% | |
| Form 10-Q Zomedica Corp. For: Mar 31 | SEC filing · Form 10-Q | -5.90% | +3.00% | |
| Form 10-K Zomedica Corp. For: Dec 31 | SEC filing · Form 10-K | +3.39% | +1.94% | |
| Form 10-Q Zomedica Corp. For: Sep 30 | SEC filing · Form 10-Q | +8.32% | +5.33% | |
| Form 10-Q Zomedica Corp. For: Jun 30 | SEC filing · Form 10-Q | +0.27% | +7.73% | |
| Form 10-Q Zomedica Corp. For: Mar 31 | SEC filing · Form 10-Q | -5.09% | -14.91% | |
| Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth | Press release | -5.09% | -14.91% | |
| Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET | Press release | -2.04% | -0.74% | |
| Form 10-K Zomedica Corp. For: Dec 31 | SEC filing · Form 10-K | +6.49% | +30.00% |
Keep exploring
More ZOM: analyst actions → · SEC filings → · ZOM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Matinas Biopharma Holdings, Inc. (MTNB) | 161 | -0.53% | 39% |
| NanoVibronix, Inc. (NAOV) | 161 | -0.40% | 39% |
| AVITA MEDICAL (AVMXY) | 160 | 0.00% | 46% |
| Adaptimmune Therapeutics plc - American Depositary Shares (ADAP) | 159 | -1.17% | 27% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.